Search research articles
Contact Us
Filters
Showing results (1-10 of 9) with videos related to
Page
of 1
Sort By:
Pharmacopsychiatry
|
August 19, 2007
Marked hypofrontality in clozapine-responsive patients
V Molina, J Sanz, F Sarramea, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
|
January 20, 2007
A 6-month prospective, observational, naturalistic, uncontrolled study to evaluate the effectiveness and tolerability of oral ziprasidone in patients with schizophrenia
C Arango, M Gómez-Beneyto, J Brenlla, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists
|
October 2, 2007
Dorsolateral prefrontal N-acetyl-aspartate concentration in male patients with chronic schizophrenia and with chronic bipolar disorder
V Molina, J Sánchez, J Sanz, et al.
The British Journal of Psychiatry : the Journal of Mental Science
|
March 2, 2005
Hypofrontality in men with first-episode psychosis
V Molina, J Sanz, S Reig, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|
September 29, 2007
Differential clinical, structural and P300 parameters in schizophrenia patients resistant to conventional neuroleptics
V Molina, S Reig, J Sanz, et al.
Schizophrenia Research
|
May 10, 2001
P300 amplitude as a possible correlate of frontal degeneration in schizophrenia
M Martín-Loeches, V Molina, F Muñoz, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists
|
February 15, 2015
Predictive factors of functional capacity and real-world functioning in patients with schizophrenia
I Menendez-Miranda, M P Garcia-Portilla, L Garcia-Alvarez, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists
|
February 26, 2021
Chronic obstructive pulmonary disease in severe mental illness: A timely diagnosis to advance the process of quitting smoking
M J Jaen-Moreno, N Feu, G I Del Pozo, et al.
Schizophrenia Research
|
June 20, 2020
Smoking cessation improves clinical outcome in severe mental disorders and is modulated by genetic variability at CHRNA5 gene
A G Segura, M Mitjans, M Fatjó-Vilas, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 9) with videos related to
Sort By:
Page
of 1
Pharmacopsychiatry
|
August 19, 2007
Marked hypofrontality in clozapine-responsive patients
V Molina, J Sanz, F Sarramea, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
|
January 20, 2007
A 6-month prospective, observational, naturalistic, uncontrolled study to evaluate the effectiveness and tolerability of oral ziprasidone in patients with schizophrenia
C Arango, M Gómez-Beneyto, J Brenlla, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists
|
October 2, 2007
Dorsolateral prefrontal N-acetyl-aspartate concentration in male patients with chronic schizophrenia and with chronic bipolar disorder
V Molina, J Sánchez, J Sanz, et al.
The British Journal of Psychiatry : the Journal of Mental Science
|
March 2, 2005
Hypofrontality in men with first-episode psychosis
V Molina, J Sanz, S Reig, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|
September 29, 2007
Differential clinical, structural and P300 parameters in schizophrenia patients resistant to conventional neuroleptics
V Molina, S Reig, J Sanz, et al.
Schizophrenia Research
|
May 10, 2001
P300 amplitude as a possible correlate of frontal degeneration in schizophrenia
M Martín-Loeches, V Molina, F Muñoz, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists
|
February 15, 2015
Predictive factors of functional capacity and real-world functioning in patients with schizophrenia
I Menendez-Miranda, M P Garcia-Portilla, L Garcia-Alvarez, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists
|
February 26, 2021
Chronic obstructive pulmonary disease in severe mental illness: A timely diagnosis to advance the process of quitting smoking
M J Jaen-Moreno, N Feu, G I Del Pozo, et al.
Schizophrenia Research
|
June 20, 2020
Smoking cessation improves clinical outcome in severe mental disorders and is modulated by genetic variability at CHRNA5 gene
A G Segura, M Mitjans, M Fatjó-Vilas, et al.
Page
of 1